| William White Eggimann, MD | |
|
700 Chief Eddie Hoffman Highway, Bethel, AK 99559-0287 | |
| (907) 543-6300 | |
| Not Available |
| Full Name | William White Eggimann |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 700 Chief Eddie Hoffman Highway, Bethel, Alaska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760698203 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 3543 (Alaska) | Primary |
| Entity Name | Yukon-kuskokwim Health Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447477815 PECOS PAC ID: 5193718765 Enrollment ID: O20040407001515 |
News Archive
Researchers in the United States have conducted a study showing that the coronavirus disease 2019 (COVID-19) vaccines developed by Pfizer-BioNTech and Moderna generate a coordinated adaptive immune response that is capable of eliciting recall responses to future infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
In his 2014 State of the Union address, President Barack Obama referred to an August 2013 Centers for Disease Control and Prevention study that showed a decline in the obesity rate among low-income pre-school children, saying, "Michelle's Let's Move! partnership with schools, businesses and local leaders has helped bring down childhood obesity rates for the first time in 30 years, and that's an achievement that will improve lives and reduce health care costs for decades to come."
As the leading cause of death in both the United States and the world, heart disease claims nearly 18 million lives every year, according to the World Health Organization.
Bayer HealthCare and Onyx Pharmaceuticals today announced that the U.S. Food and Drug Administration has granted Priority Review designation to the supplemental New Drug Application for the oral multi-kinase inhibitor Nexavar (sorafenib) tablets under evaluation for the treatment of locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer.
Offering patients a roster of clinicians on their care team increased recognition of each clinician's name and face during their treatment period, something patients also reported as highly significant to their care, according to research presented at American College of Cardiology Quality Summit Virtual, taking place Sept. 29 – Oct. 1, 2021.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William White Eggimann, MD Po Box 287, Bethel, AK 99559-0287 Ph: () - | William White Eggimann, MD 700 Chief Eddie Hoffman Highway, Bethel, AK 99559-0287 Ph: (907) 543-6300 |
News Archive
Researchers in the United States have conducted a study showing that the coronavirus disease 2019 (COVID-19) vaccines developed by Pfizer-BioNTech and Moderna generate a coordinated adaptive immune response that is capable of eliciting recall responses to future infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
In his 2014 State of the Union address, President Barack Obama referred to an August 2013 Centers for Disease Control and Prevention study that showed a decline in the obesity rate among low-income pre-school children, saying, "Michelle's Let's Move! partnership with schools, businesses and local leaders has helped bring down childhood obesity rates for the first time in 30 years, and that's an achievement that will improve lives and reduce health care costs for decades to come."
As the leading cause of death in both the United States and the world, heart disease claims nearly 18 million lives every year, according to the World Health Organization.
Bayer HealthCare and Onyx Pharmaceuticals today announced that the U.S. Food and Drug Administration has granted Priority Review designation to the supplemental New Drug Application for the oral multi-kinase inhibitor Nexavar (sorafenib) tablets under evaluation for the treatment of locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer.
Offering patients a roster of clinicians on their care team increased recognition of each clinician's name and face during their treatment period, something patients also reported as highly significant to their care, according to research presented at American College of Cardiology Quality Summit Virtual, taking place Sept. 29 – Oct. 1, 2021.
› Verified 5 days ago
Jill Seaman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 Chief Eddie Hoffman Highway, Bethel, AK 99559 Phone: 907-543-6300 | |
Daniel Hartman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 Chief Eddie Hoffman Highway, Bethel, AK 99559 Phone: 907-543-6300 | |
Calvin Vermeire, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Yukon Kuskokwim Health Corportation, Chief Eddy Hoffman Highway, Bethel, AK 99559 Phone: 907-543-6300 | |
Elizabeth Jane Roll, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 Chief Eddie Hoffman Highway, Bethel, AK 99559 Phone: 907-543-6300 | |
Scott A Walker, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 700 Chief Eddie Hoffman, Kusko Clinic, Bethel, AK 99559 Phone: 907-543-6300 Fax: 907-543-6250 | |
Joseph Klejka, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 Chief Eddie Hoffman Highway, Bethel, AK 99559 Phone: 907-543-6300 |